Detection of ALK fusion transcripts in FFPE lung cancer samples by NanoString technology

BACKGROUND: ALK-rearranged lung cancers exhibit specific pathologic and clinical features and are responsive to anti-ALK therapies. Therefore, the detection of ALK-rearrangement is fundamental for personalized lung cancer therapy. Recently, new molecular techniques, such as NanoString nCounter, have...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Pulm Med
Päätekijät: Evangelista, Adriane F., Zanon, Maicon F., Carloni, Adriana Cruvinel, de Paula, Flávia E., Morini, Mariana Andozia, Ferreira-Neto, Maressa, Soares, Iberê Cauduro, Miziara, Jose Elias, de Marchi, Pedro, Scapulatempo-Neto, Cristovam, Reis, Rui M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2017
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5446704/
https://ncbi.nlm.nih.gov/pubmed/28549458
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-017-0428-0
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia